Class Action Filed Against Treace Medical Concepts, Inc. (TMCI) - June 10, 2025 Deadline to Join - Contact The Gross Law Firm

Core Viewpoint - Treace Medical Concepts, Inc. (NASDAQ: TMCI) is facing allegations of issuing materially false and misleading statements regarding its primary product, the 3D bunion correction system, "Lapiplasty," which has led to a decline in revenue and necessitated a shift in product strategy [1][2]. Group 1: Allegations and Impact - The complaint alleges that competition has negatively impacted the demand and utilization of the "Lapiplasty" system [1]. - As a result of the competitive pressures, Treace Medical's revenue has declined, prompting the company to accelerate plans for an alternative product to osteotomy [1]. - The defendants' positive statements about the company's business and prospects were found to be materially misleading and lacked a reasonable basis [1]. Group 2: Class Action Details - Shareholders who purchased TMCI shares during the class period from May 8, 2023, to May 7, 2024, are encouraged to register for the class action [2]. - The deadline for shareholders to seek lead plaintiff status is June 10, 2025, and there is no cost or obligation to participate in the case [2]. Group 3: Law Firm Background - The Gross Law Firm is a nationally recognized class action law firm dedicated to protecting the rights of investors affected by deceit and illegal business practices [3]. - The firm aims to ensure companies adhere to responsible business practices and seeks recovery for investors who suffered losses due to misleading statements [3].